These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2180232)

  • 1. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PhoP virulence regulon and live oral Salmonella vaccines.
    Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
    Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated vaccines for invasive Salmonella infections.
    Tennant SM; Levine MM
    Vaccine; 2015 Jun; 33 Suppl 3(0 3):C36-41. PubMed ID: 25902362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.
    Robbe-Saule V; Norel F
    FEMS Microbiol Lett; 1999 Jan; 170(1):141-3. PubMed ID: 9919662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
    Levine MM; Hone D; Tacket C; Ferreccio C; Cryz S
    Res Microbiol; 1990; 141(7-8):807-16. PubMed ID: 2101470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in vaccines against typhoid fever.
    Levine MM; Ferreccio C; Black RE; Tacket CO; Germanier R
    Rev Infect Dis; 1989; 11 Suppl 3():S552-67. PubMed ID: 2669099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
    Chen QY; Jiang LJ; Kong DC; Wang BR
    Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
    [No Abstract]   [Full Text] [Related]  

  • 15. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live bacterial vaccines and their application as carriers for foreign antigens.
    Dougan G; Smith L; Heffron F
    Adv Vet Sci Comp Med; 1989; 33():271-300. PubMed ID: 2648775
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.
    Hohmann EL; Oletta CA; Miller SI
    Vaccine; 1996 Jan; 14(1):19-24. PubMed ID: 8821644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
    Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
    Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated Salmonella: a paradigm of mucosal vaccines.
    Sirard JC; Niedergang F; Kraehenbuhl JP
    Immunol Rev; 1999 Oct; 171():5-26. PubMed ID: 10582163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.